feed,title,long_url,short_url
BioRxiv,Virological characteristics of the SARS-CoV-2 Omicron BA.2.75,https://biorxiv.org/cgi/content/short/2022.08.07.503115v1?rss=1,https://bit.ly/3p1MfTp
BioRxiv,Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir,https://biorxiv.org/cgi/content/short/2022.08.07.499047v1?rss=1,https://bit.ly/3SCEMYE
BioRxiv,A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations,https://biorxiv.org/cgi/content/short/2022.08.06.503039v1?rss=1,https://bit.ly/3BMQE47
BioRxiv,Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors,https://biorxiv.org/cgi/content/short/2022.08.07.503099v1?rss=1,https://bit.ly/3dgMIi0
BioRxiv,Human immune and gut microbial parameters associated with inter-individual variations in COVID-19 mRNA vaccine-induced immunity,https://biorxiv.org/cgi/content/short/2022.08.08.503075v1?rss=1,https://bit.ly/3dhHhPR
BioRxiv,"The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2, Necroptosis, Pyroptosis and Panoptosis",https://biorxiv.org/cgi/content/short/2022.08.06.503050v1?rss=1,https://bit.ly/3p4GtRa
